Meta-Analysis
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1079-1094
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1079
Table 1 Patient profile of included studies (distribution, age, sex, and pathology)
Ref.Number
Age
Sex (M/F)
Pathology
Steroid
Control
Steroid
Control
Steroid
Control

Steroid
Control
Donadon et al[13], 2016161665 (27-80)163 (22-77)110/69/7Metastasis612
HCC62
Cholangiocarcinoma40
Others02
Hasegawa et al[15], 2020505067 (59-74)268 (62–75)230/2031/19Metastasis2114
Hayashi et al[12], 20111029869 (39-81)170 (35-82)1--Metastasis3223
HCC6366
Cholangiocarcinoma65
Others14
Muratore et al[20], 2003252865.4 ± 10.8364.1 ± 11.738/1711/17---
Pulitanò et al[17], 2007373663 (31-85)461.8 (21-78)423/1422/14Metastasis1614
HCC1214
Cholangiocarcinoma54
Hemangioendothelioma11
Benign33
Schmidt et al[18], 200710105756553/74/6HCC21
Metastasis44
Cholangiocarcinoma02
Benign43
Yamashita et al[16], 2001171660.3 ± 1.8656.8 ± 3.964/1311/5 HCC138
Metastasis03
Cholangiocarcinoma01
Living donor of transplant44
Zi et al[19], 2015403957.55 ± 8.81357.51 ± 10.32323/1717/22Malignant3134
Benign95
Table 2 Surgical details of included studies (type of resection, duration, blood loss and volume resected)
Ref.Type of resection
Duration of operation/min
Volume of blood loss/mL
Volume of liver resected/g

Steroid
Control
Steroid
Control
Steroid
Control
Steroid
Control
Donadon et al[13], 2016Minor911383.5 (235-546)1351 (226-640)1275 (100-1000)1200 (0-700)1--
Major75
Hasegawa et al[15], 2020Minor4039215 (170-294)2233 (157-270)252 (29-149)234 (17-76)2--
Major1011
Hayashi et al[12], 2011Hemihepactectomy1115330 (165-834)1316 (136-697)1324 (5-1577)1257 (10-1972)177 (4-1930)175 (6-1300)1
Segmentectomy5957
Limited resection3226
Muratore et al[20], 2003Minor1213--322.8 ± 261.43294.6 ± 271.93--
Major1315
Pulitanò et al[17], 2007Right hepactectomy1110440 (220-480)1408 (240-460)1662 (300-800)1621 (350-720)140.4 ± 203 (%)39.5 ± 183 (%)
Left hepatectomy68
Extended right hepatectomy54
Extended left hepatectomy22
Bisegmentectomy64
Segmentectomy45
Wedge resection33
Schmidt et al[18], 2007Segment II/III452224252434047804--
Segment V-VIII65
Yamashita et al[16], 2001Lobectomy or more56338 ± 215352 ± 145892 ± 1065822 ± 555239 ± 505187 ± 335
Segmentectomy21
Subsegmentectomy or less109
Zi et al[19], 2015Major2212342.38 ± 129.733353.21 ± 168.363481.25 ± 415.983496.15 ± 391.593--
Minor1827
Table 3 Perioperative steroid protocols of included studies
Ref.
Study design
Country
Steroid protocol
Control protocol
Donadon et al[13], 2016RCTItalyPreoperative bolus infusion (5%) of 500 mg methylprednisolone in 250 mL glucose for 1 h prior to hepatectomy, then continuous infusion for 6 h250 mL glucose-5% as bolus and subsequent continuous infusion
Hasegawa et al[15], 2020RCTJapanPreoperative, up to 500 mg methylprednisolone in saline solutionSaline only
Hayashi et al[12], 2011RCTJapanIntraoperative 500 mg hydrocortisone immediately prior to hepatic-pedicle clamping 300 mg hydrocortisone on POD1 200 mg on POD 2, 100 mg on POD30
Muratore et al[20], 2003RCTItalyPreoperative (30 min before surgery) 30 mg/kg per body weight IV methylprednisolone0
Pulitanòet al[17], 2007RCTItalyPreoperative 500 mg methylprednisolone0
Schmidt et al[18], 2007RCTGermanyPreoperative (90 min before surgery) 30 mg/kg per body weight IV methylprednisolone50 mL IV saline
Yamashita et al[16], 2001RCTJapanPreoperative (2 h before surgery) 500 mg IV methylprednisolone0
Zi et al[19], 2015RCTChinaIntraoperative 500 mg methylprednisolone prior to liver resectionHepatectomy only